Vertex Pharmaceuticals Incorporated: A Leader in Biotechnology Innovation
October 9, 2025
Vertex Pharmaceuticals Incorporated VRTX - Leading the Way in Rare Disease Treatments
August 15, 2025
VERTEX PHARMACEUTICALS INCORPORATED Hits 10.2% Profit Target Forecast by QuantWave
August 8, 2025
VERTEX PHARMACEUTICALS Stock Hits Target Forecast with 8.98% Profit
August 8, 2025
VERTEX PHARMACEUTICALS Stock Hits Target Price with 10.23% Profit: QuantWave Forecast Success
August 8, 2025
VERTEX PHARMACEUTICALS INCORPORATED Successfully Hits Price Target Forecast with 16.01% Profit: A Triumph for QuantWave's Analytics
August 5, 2025
Jim Cramer on Vertex Pharmaceuticals' Suzetrigine: Limited Upside Potential for Drug of the Future
January 31, 2025
Vertex Pharmaceuticals Incorporated VRTX to Unveil Q4 2024 Financial Results on February 10
February 3, 2025
Vertex Pharmaceuticals Stock Jumps as Non-Opioid Painkiller Gets FDA Approval
February 4, 2025
Jim Cramer Fires a Warning: What's Next for Vertex Pharmaceuticals VRTX?
January 2, 2025
Jim Cramer Fires a Warning on Vertex Pharmaceuticals: Should You Buy the Stock?
January 2, 2025
Investor opinions & comments
To leave a comment, you need to Login or Register.
InvestorIsabella
February 5, 2025 at 19:37
It's exciting to see Vertex Pharmaceuticals making strides with Suzetrigine. I have confidence in the company's ability to succeed
SmartSabrina
February 5, 2025 at 11:51
This is great news for Vertex Pharmaceuticals! I'm really interested in learning more about Suzetrigine and how it can drive the company's growth
CashChris
February 4, 2025 at 03:52
Jim Cramer's recognition of Vertex Pharmaceuticals' underlying strength is reassuring. I'm positive about the future prospects of the company
FinanceFlo
February 3, 2025 at 10:15
I'm optimistic about the potential growth of Vertex Pharmaceuticals thanks to the promising prospects of Suzetrigine. It's definitely worth keeping an eye on this stock
CashCathy
February 3, 2025 at 06:32
I agree with Jim Cramer that seeking professional advice, like Stocks Prognosis, can help investors make a more informed decision about Vertex's future growth
JustinMitchell
February 3, 2025 at 01:53
While Suzetrigine may be a promising drug, there are always risks involved in the pharmaceutical industry. It's worth considering the potential challenges and competition Vertex may face
DylanRamos
February 2, 2025 at 10:04
I'm eager to see how Suzetrigine performs in the market and how it can impact the future financials of Vertex Pharmaceuticals
SmartSteve
February 2, 2025 at 04:22
I'm not entirely convinced about the upside potential of Vertex stock. I think it's important to conduct thorough research before making any investment decisions